Sabine Ivison

2.6k total citations · 1 hit paper
30 papers, 665 citations indexed

About

Sabine Ivison is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Sabine Ivison has authored 30 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Sabine Ivison's work include Immune Cell Function and Interaction (9 papers), Immune Response and Inflammation (9 papers) and T-cell and B-cell Immunology (8 papers). Sabine Ivison is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Immune Response and Inflammation (9 papers) and T-cell and B-cell Immunology (8 papers). Sabine Ivison collaborates with scholars based in Canada, United States and Australia. Sabine Ivison's co-authors include Theodore S. Steiner, Megan K. Levings, Laura Cook, Rosa V. Garcia, Megan E. Himmel, Timothy J. Kieffer, Kirsten A. Ward‐Hartstonge, Peter T. W. Kim, David Thompson and Jackson Loyal and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Cell stem cell.

In The Last Decade

Sabine Ivison

29 papers receiving 657 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes

2021 211 citations Adam Ramzy, David Thompson et al. Cell stem cell profile →

Peers

Countries citing papers authored by Sabine Ivison

Since Specialization

Citations

This map shows the geographic impact of Sabine Ivison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Ivison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Ivison more than expected).

Fields of papers citing papers by Sabine Ivison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Ivison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Ivison. The network helps show where Sabine Ivison may publish in the future.

Co-authorship network of co-authors of Sabine Ivison

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Ivison. A scholar is included among the top collaborators of Sabine Ivison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Ivison. Sabine Ivison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune phenotyping in a pediatric multicenter transplant study: Suitability of a preformulated dry-antibody panel system 2024 ·Human Immunology ·Lavinia Ionescu, Tom Blydt‐Hansen, Bethany J. Foster, Upton Allen, Patricia E. Birk, Lorraine Hamiwka, Véronique Phan, (unknown), Sabine Ivison, Megan K. Levings, Lori J. West, Seema Mital, Simon Urschel	0
2	Improving Reliability of Immunological Assays by Defining Minimal Criteria for Cell Fitness 2024 ·ImmunoHorizons ·Sabine Ivison, Gabrielle Boucher, Grace Zheng, Rosa V. Garcia, Rita Kohen, Alain Bitton, John D. Rioux, Megan K. Levings	3
3	SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain 2023 ·Transplantation ·(unknown), Sabine Ivison, Qing Huang, (unknown), (unknown), Dhiraj Mannar, Sriram Subramaniam, Victor H. Ferreira, Deepali Kumar, Sara Belga, Megan K. Levings, (unknown)	1
4	T‐cell activation–induced marker assays in health and disease 2023 ·Immunology and Cell Biology ·(unknown), (unknown), Sabine Ivison, Megan K. Levings, Theodore S. Steiner, Laura Cook	45
5	Strategies for optimizing CITE-seq for human islets and other tissues 2023 ·Frontiers in Immunology ·(unknown), Matthew Budd, (unknown), (unknown), Julia Murphy, Sabine Ivison, C. Bruce Verchere, Megan K. Levings, Sarah Q. Crome	6
6	Modelling Graft-Versus-Host Disease in Mice Using Human Peripheral Blood Mononuclear Cells 2022 ·BIO-PROTOCOL ·Manjurul Haque, Dominic A. Boardman, (unknown), Katherine N. MacDonald, Lieke Sanderink, Qing Huang, Vivian Fung, Sabine Ivison, Majid Mojibian, Megan K. Levings	7
7	Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory T cells 2022 ·Cytotherapy ·Katherine N. MacDonald, Michael G. Hall, Sabine Ivison, Sanjiv K. Gandhi, Ramon I. Klein Geltink, James M. Piret, Megan K. Levings	8
8	Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid- Refractory or Dependent Chronic GVHD – a Multicentre Phase II Clinical Trial (CARE Trial) 2021 ·Transplantation and Cellular Therapy ·Imran Ahmad, Janet J. Bijl, Sabine Ivison, Eshetu G. Atenafu, Tony Panzarella, Raewyn Broady, David Szwajcer, Irwin Walker, Dennis Dong Hwan Kim, Christopher Bredeson, Ronan Foley, Donna E. Hogge, David Allan, Jean‐Sébastien Delisle, Kirk R. Schultz, Donna A. Wall, Megan K. Levings, Denis‐Claude Roy	1
9	Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes breakdown → 2021 ·Cell stem cell ·Adam Ramzy, David Thompson, Kirsten A. Ward‐Hartstonge, Sabine Ivison, Laura Cook, Rosa V. Garcia, Jackson Loyal, Peter T. W. Kim, Garth L. Warnock, Megan K. Levings, Timothy J. Kieffer	211
10	Pharmacological inhibition of RORC2 enhances human Th17‐Treg stability and function 2020 ·European Journal of Immunology ·Dominic A. Boardman, Rosa V. Garcia, Sabine Ivison, Brian Bressler, (unknown), Qihong Zhao, Megan K. Levings	17
11	Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol 2019 ·Cytotherapy ·Katherine N. MacDonald, Sabine Ivison, Keli L. Hippen, Romy E. Hoeppli, Michael G. Hall, Grace Zheng, E. Dijke, (unknown), Darren H. Freed, Ivan M. Rebeyka, Sanjiv K. Gandhi, Lori J. West, James M. Piret, Bruce R. Blazar, Megan K. Levings	20
12	Human Regulatory T Cell Potential for Tissue Repair Via IL-33/ST2 and Amphiregulin 2018 ·Transplantation ·(unknown), Haiming Huang, James Pan, Sachdev S. Sidhu, Guy Charron, Sabine Ivison, John D. Rioux, Megan K. Levings	1
13	Biomarker-guided stratification of autoimmune patients for biologic therapy 2017 ·Current Opinion in Immunology ·Sabine Ivison, Christine Des Rosiers, Sylvie Lesage, John D. Rioux, Megan K. Levings	7
14	Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens 2011 ·Biology of Blood and Marrow Transplantation ·Hisaki Fujii, Sabine Ivison, Hiromi Shimizu, Ryosuke Kajiwara, Amina Kariminia, Matthew Yan, Jan Dutz, Kirk R. Schultz	7
15	Autoactivation of the AggR regulator of enteroaggregativeEscherichia coli in vitroandin vivo 2010 ·FEMS Immunology & Medical Microbiology ·Nicholas Morin, (unknown), Sabine Ivison, Ajinder Kaur, James P. Nataro, Theodore S. Steiner	6
16	Protein kinase D1 and D2 are involved in chemokine release induced by toll-like receptors 2, 4, and 5 2010 ·Cellular Immunology ·Theodore S. Steiner, Sabine Ivison, Yu Yao, (unknown)	17
17	The Stress signal extracellular ATP modulates antiflagellin immune responses in intestinal epithelial cells 2010 ·Inflammatory Bowel Diseases ·Sabine Ivison, Megan E. Himmel, (unknown), Yu Yao, (unknown), Megan K. Levings, Theodore S. Steiner	20
18	Human CD4⁺FOXP3⁺ regulatory T cells produce CXCL8 and recruit neutrophils 2010 ·European Journal of Immunology ·Megan E. Himmel, Sarah Q. Crome, Sabine Ivison, Ciriaco A. Piccirillo, Theodore S. Steiner, Megan K. Levings	69
19	Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin 2010 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Sabine Ivison, Ce Wang, Megan E. Himmel, (unknown), (unknown), (unknown), Yu Yao, (unknown), Theodore S. Steiner	27
20	Anti‐flagellin antibodies in irritable bowel syndrome: another attack on our commensals? 2008 ·Neurogastroenterology & Motility ·Sabine Ivison, Theodore S. Steiner	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact